Lisa Rojkjaer - 16 Mar 2023 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Reporting relationship: Chief Medical Officer
Issuer ticker: VIRX
Reported as of: 16 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Mar 2023, 17:03:25 UTC
Prior SEC filing: 28 Feb 2023
Next SEC filing: 29 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Daniel Chevallard, as Attorney-in-Fact

Key filing fact

Lisa Rojkjaer filed Form 4 for Viracta Therapeutics, Inc. (VIRX) on 17 Mar 2023.

Key facts

This page summarizes Lisa Rojkjaer's Form 4 filing for Viracta Therapeutics, Inc. (VIRX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Mar 2023, 17:03.

Change

Previous filing in this sequence was filed on 28 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIRX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +150,000
Change %
Price: $0.000000
Shares after: 150,000
Date: 16 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $1.65
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/48th of the total shares subject to the Option will vest each month on the same day of the month as the Vesting Commencement Date (as defined below), and if there is no corresponding day, the last day of the month, subject to the Reporting Person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is January 1, 2023.